|
We are internally focused on using our technologies to develop and commercialize proprietary RNAi therapeutics. Calando's proprietary technologies have applications well beyond our capacity to develop internally. Consequently, we continually seek additional partnerships to advance the development of our technologies.
PARTNERSHIP OPPORTUNITIES
Calando is seeking additional strategic collaborations with pharmaceutical and biotechnology companies whose products or proprietary development compounds might benefit from Calando's technologies and expertise. Interested parties should contact Thomas Schluep at 626.304.3400 tschluep@calandopharma.com
|
